Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features
- PMID: 20649802
- DOI: 10.1111/j.1469-0691.2010.03298.x
Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features
Abstract
Escherichia coli is one of the major pathogens responsible for bactaeremia. Empirical antibiotherapy of these infections usually relies on third-generation cephalosporins (3GCs). Thus, the occurrence and epidemiology of 3GC-resistant strains have to be monitored. The French prospective multicentre study COLIBAFI collected 1081 strains of E. coli responsible for bacteraemia in 2005. In the present work, the prevalence of resistance to 3GCs was evaluated, and the implicated molecular mechanisms were characterized by specific PCR and sequencing. Phylogenetic grouping, O-typing, pulsed-field gel electrophoresis and virulence factor analysis were used to investigate the genetic background of the 3GC-resistant (3GC-R) strains. Clinical features of the patients with documented data (n = 1051) were analysed. Decreased susceptibility to 3GCs was observed in 41 strains (3.8%): 19, 18 and four had extended-spectrum β-lactamase (ESBL), AmpC cephalosporinase and OXA-type penicillinase phenotypes, respectively. Pulsed-field gel electrophoresis revealed that the 3GC-R strains constitute a diverse population. All but one of the strains with an ESBL phenotype produced a CTX-M-type enzyme, and six of them belonged to the widespread intercontinental clone O25b:H4-ST131. AmpC phenotype strains harboured various chromosomal ampC promoter and coding region mutations and/or the bla(CMY-2) plasmidic gene. 3GC-R strains carried fewer virulence factors and were more co-resistant to other antibiotics than 3GC-susceptible (3GC-S) strains. Infections with 3GC-R strains were mostly community-acquired and, as compared with those caused by their 3GC-S counterparts, were more severe. Underlying chronic disease and prior use of antibiotics were independent risk factors for development of a 3GC-R strain bacteraemia. The fact that the molecular support of 3GC resistance is mainly plasmid-mediated represents a potentially epidemic threat.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.
Similar articles
-
Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia.Clin Microbiol Infect. 2013 Feb;19(2):161-8. doi: 10.1111/j.1469-0691.2012.03762.x. Epub 2012 Feb 14. Clin Microbiol Infect. 2013. PMID: 22332968
-
Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.Microb Drug Resist. 2014 Aug;20(4):316-24. doi: 10.1089/mdr.2013.0157. Epub 2014 Feb 11. Microb Drug Resist. 2014. PMID: 24517383
-
WGS-based surveillance of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark.J Antimicrob Chemother. 2017 Jul 1;72(7):1922-1929. doi: 10.1093/jac/dkx092. J Antimicrob Chemother. 2017. PMID: 28369408
-
Global Distribution of Extended Spectrum Cephalosporin and Carbapenem Resistance and Associated Resistance Markers in Escherichia coli of Swine Origin - A Systematic Review and Meta-Analysis.Front Microbiol. 2022 May 10;13:853810. doi: 10.3389/fmicb.2022.853810. eCollection 2022. Front Microbiol. 2022. PMID: 35620091 Free PMC article. Review.
-
Prevalence and outcome of bloodstream infections due to third-generation cephalosporin-resistant Enterobacteriaceae in sub-Saharan Africa: a systematic review.J Antimicrob Chemother. 2020 Mar 1;75(3):492-507. doi: 10.1093/jac/dkz464. J Antimicrob Chemother. 2020. PMID: 31742611 Free PMC article.
Cited by
-
Human and avian extraintestinal pathogenic Escherichia coli: infections, zoonotic risks, and antibiotic resistance trends.Foodborne Pathog Dis. 2013 Nov;10(11):916-32. doi: 10.1089/fpd.2013.1533. Epub 2013 Aug 20. Foodborne Pathog Dis. 2013. PMID: 23962019 Free PMC article. Review.
-
Extended-spectrum β-lactamases: an update on their characteristics, epidemiology and detection.JAC Antimicrob Resist. 2021 Jul 16;3(3):dlab092. doi: 10.1093/jacamr/dlab092. eCollection 2021 Sep. JAC Antimicrob Resist. 2021. PMID: 34286272 Free PMC article. Review.
-
The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx.mBio. 2013 Dec 17;4(6):e00377-13. doi: 10.1128/mBio.00377-13. mBio. 2013. PMID: 24345742 Free PMC article.
-
Characterization of extended-spectrum-beta-lactamase-producing Escherichia coli strains involved in maternal-fetal colonization: prevalence of E. coli ST131.J Clin Microbiol. 2013 Jun;51(6):1727-32. doi: 10.1128/JCM.03255-12. Epub 2013 Mar 20. J Clin Microbiol. 2013. PMID: 23515552 Free PMC article.
-
Multidrug resistant AmpC β-lactamase producing Escherichia coli isolated from a paediatric hospital.Pak J Med Sci. 2014 Jan;30(1):181-4. doi: 10.12669/pjms.301.4045. Pak J Med Sci. 2014. PMID: 24639857 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical